Latest Breaking News On - Anixa bioscience - Page 1 : vimarsana.com

Financial Contrast: Anixa Biosciences (NASDAQ:ANIX) vs. MacroGenics (NASDAQ:MGNX)

PainReform (NASDAQ:PRFX) & Anixa Biosciences (NASDAQ:ANIX) Financial Comparison

Contrasting Anixa Biosciences (NASDAQ:ANIX) & PainReform (NASDAQ:PRFX)

Contrasting Anixa Biosciences (NASDAQ:ANIX) & MacroGenics (NASDAQ:MGNX)

Anixa Biosciences (NASDAQ:ANIX) Stock Rating Reaffirmed by HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $12.00 price objective on the stock. HC Wainwright also issued estimates for Anixa Biosciences’ FY2025 earnings at ($0.40) EPS. Anixa Biosciences Price Performance […]

We Think Anixa Biosciences (NASDAQ:ANIX) Can Easily Afford To Drive Business Growth

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

Breast cancer vaccine advancing through testing; woman with Florida connections first to take it

A new vaccine hopes to protect against one of the more deadly forms of the cancer, and an Orlando woman was the first to take it! FOX 35 News introduced you to Jenni Davis back in April.

Anixa Biosciences, Inc. to Post FY2023 Earnings of ($0.32) Per Share, HC Wainwright Forecasts (NASDAQ:ANIX)

Here's Why We're Not Too Worried About Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Situation

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Equities Analysts Offer Predictions for Anixa Biosciences, Inc.'s FY2023 Earnings (NASDAQ:ANIX)

Anixa Biosciences, Inc. (NASDAQ:ANIX – Free Report) – Investment analysts at Chardan Capital issued their FY2023 earnings estimates for Anixa Biosciences in a research note issued to investors on Monday, July 10th. Chardan Capital analyst M. Barcus expects that the company will post earnings of ($0.45) per share for the year. Chardan Capital has a […]